Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis

被引:244
|
作者
Schmidt, W. A. [1 ]
Seifert, A. [1 ]
Gromnica-Ihle, E. [1 ]
Krause, A. [1 ]
Natusch, A. [1 ]
机构
[1] Med Ctr Rheumatol Berlin Buch, D-13125 Berlin, Germany
关键词
temporal arteritis; giant cell arteritis; large-vessel giant cell arteritis; ultrasonography; colour Doppler ultrasonography; angiography; magnetic resonance imaging;
D O I
10.1093/rheumatology/kem322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To describe characteristic ultrasound findings and clinical features of patients with newly diagnosed cranial and large-vessel (LV) GCA in a specialized ultrasound clinic. Methods. This case - control study includes all consecutive patients between 1997 and 2006 with newly diagnosed GCA. Duplex ultrasound of the temporal, subclavian, axillary and proximal brachial arteries was performed in all patients with suspected temporal arteritis, PMR, arm claudication, unclear inflammation or pyrexia of unknown origin (PUO). Results. In 53 of 176 patients, ultrasound depicted characteristic vasculitic homogeneous wall swelling of the axillary, subclavian and/or proximal brachial arteries. These were affected in 98, 61 and 21%, respectively, in the 53 patients. The findings were bilateral in 79%. Axillary arteries were stenotic or occluded in 51 and 2% and temporal artery ultrasound and histology were positive in 62 and 67% of LV-GCA cases, respectively. A significantly greater number of LV-GCA patients were female (83 vs 65%) and younger (mean 66 vs 72 yrs) as compared with those without proximal arm involvement. Headaches (38 vs 75%), jaw claudication (24 vs 48%) and anterior ischaemic optic neuropathy (4 vs 19%) occurred significantly less frequently. The median time until diagnosis was significantly longer (31 vs 8 weeks). ESR and presence of PMR were similar in both groups. Conclusions. Performing axillary artery ultrasound in all patients with suspected temporal arteritis, PMR, arm claudication, unclear inflammation or PUO increases the diagnostic yield for LV-GCA. Patients with LV-GCA differ from those without arm involvement.
引用
收藏
页码:96 / 101
页数:6
相关论文
共 50 条
  • [41] Ultrasound to Monitor Treatment Response in Large Vessel Giant Cell Arteritis
    Haaversen, Anne Bull
    Holt, Viktoria
    Nabizadeh, Shagaye
    Slagsvold, Annicken
    Diamantopoulos, Andreas P.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [42] LARGE-VESSEL ARTERIAL OCCLUSIVE DISEASE IN SYMPTOMATIC UPPER EXTREMITY
    HARRIS, RW
    ANDROS, G
    DULAWA, LB
    OBLATH, RW
    SALLESCUNHA, SX
    APYAN, R
    ARCHIVES OF SURGERY, 1984, 119 (11) : 1277 - 1282
  • [43] Giant-Cell Arteritis: Do We Treat Patients with Large-Vessel Involvement Differently?
    de Boysson, Hubert
    Liozon, Eric
    Lambert, Marc
    Dumont, Anael
    Boutemy, Jonathan
    Maigne, Gwenola
    Silva, Nicolas Martin
    Ly, Kim Heang
    Manrique, Alain
    Bienvenu, Boris
    Aouba, Achille
    AMERICAN JOURNAL OF MEDICINE, 2017, 130 (08): : 992 - 995
  • [44] Diagnostic yield of combined cranial and large vessel PET/CT, ultrasound and MRI in giant cell arteritis: A systematic review and meta-analysis
    Moreel, Lien
    Betrains, Albrecht
    Doumen, Michael
    Molenberghs, Geert
    Vanderschueren, Steven
    Blockmans, Daniel
    AUTOIMMUNITY REVIEWS, 2023, 22 (07)
  • [45] Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy
    Berit Dalsgaard Nielsen
    Lars Christian Gormsen
    Ib Tønder Hansen
    Kresten Krarup Keller
    Philip Therkildsen
    Ellen-Margrethe Hauge
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 1119 - 1128
  • [46] Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy
    Nielsen, Berit Dalsgaard
    Gormsen, Lars Christian
    Hansen, Ib Tonder
    Keller, Kresten Krarup
    Therkildsen, Philip
    Hauge, Ellen-Margrethe
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (07) : 1119 - 1128
  • [47] UTILITY OF ULTRASOUND MONITORING GIANT CELL ARTERITIS LARGE VESSEL IN CLINICAL PRACTICE
    De Miguel, E.
    Cabaleiro-Rana, N.
    Fernandez-Fernandez, E.
    Monjo-Henry, I
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83
  • [48] Giant cell arteritis with large vessel impairement
    Gambillara, E.
    Zuber, J. -P
    Schaefer, S.
    Spertini, F.
    SWISS MEDICAL WEEKLY, 2008, 138 : 54S - 54S
  • [49] Mimickers of Large Vessel Giant Cell Arteritis
    Ramon, Andre
    Greigert, Helene
    Ornetti, Paul
    Bonnotte, Bernard
    Samson, Maxime
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [50] Large vessel vasculitis (giant cell arteritis, Takayasu arteritis)
    Wilke, WS
    BAILLIERES CLINICAL RHEUMATOLOGY, 1997, 11 (02): : 285 - 313